Archive for the ‘Irritable Bowel Syndrome’ Category
The Therapeutic Effect Of Worm-Derived Proteins On Experimental Colitis
March 6th, 2010 Posted 1:00 am
Patients with inflammatory bowel disease (IBD) suffer from chronic inflammation of the gut leading to gastrointestinal motility alterations with symptoms such as abdominal pain, cramps and diarrhea that profoundly affect their quality of life…
Posted in Irritable Bowel Syndrome
Thiopurine Therapy For IBD Improves Quality Of Life
March 2nd, 2010 Posted 6:00 am
Patients with inflammatory bowel diseases (IBDs) such as Crohn’s disease or ulcerative colitis do perceive a benefit from thiopurine treatment. A report in the open access journal BMC Gastroenterology has demonstrated improved health-related quality of life in 92 IBD patients…
Posted in Irritable Bowel Syndrome
Behavioral Health Registry For Pediatric Inflammatory Bowel Disease To Be Created With NIH Grant
February 24th, 2010 Posted 1:00 am
The National Institutes of Health has awarded a two-year development grant to researchers with Hasbro Children’s Hospital and the Bradley Hasbro Children’s Research Center to better understand the role behavioral health plays in pediatric inflammatory bowel disease (IBD), a condition that causes chronic and painful inflammation in the gastrointestinal tract…
Posted in Irritable Bowel Syndrome
New Guideline Identifies Major Risk Factors In The Development Of Colorectal Cancer In Children And Adults With Inflammatory Bowel Disease
February 17th, 2010 Posted 5:00 am
Certain patients with inflammatory bowel disease (IBD), both ulcerative colitis and Crohn’s disease of the colon, have an increased risk of developing colorectal cancer compared to individuals without IBD…
Posted in Irritable Bowel Syndrome
Non-Hospitalised Patients With Active Inflammatory Bowel Disease Are 16 Times More Likely To Suffer A Blood Clot Than The General Population
February 10th, 2010 Posted 1:00 am
Non-hospitalised patients with active inflammatory bowel disease (IBD) are 16 times more likely to suffer a blood clot (venous thromboembolism) than the non-hospitalised general population. These results suggest that active IBD in ambulatory patients might be a far greater risk factor for venous thromboembolism than previously recognised, and these patients could be a target for prophylaxis…
Posted in Irritable Bowel Syndrome
Walkerton Tragedy: 10 Years Of Research Leads To Breakthrough
January 29th, 2010 Posted 12:00 am
Studies of the victims of the Walkerton, Ont. tainted drinking water tragedy have led researchers to discover DNA variations in genes that increase the risk of developing post-infectious irritable bowel syndrome (PI-IBS). The sheer scale of infection and the recording of the health of Walkerton’s citizens gave a team of researchers a unique opportunity to study the origin of this disorder…
Posted in Irritable Bowel Syndrome
Bacterial Phylotype Alterations In Irritable Bowel Syndrome
January 18th, 2010 Posted 12:00 am
Irritable bowel syndrome (IBS) is a common gastrointestinal functional disorder that can greatly affect the patient’s well being. Multiple interacting mechanisms, including alterations in the intestinal microbiota, are suspected to lie behind IBS aetiology. A research article published on December 21, 2009 in the World Journal of Gastroenterology addresses this problem…
Posted in Irritable Bowel Syndrome
GSK Exercises Option To Progress Development Of ChemoCentryx’s Traficet-EN For The Treatment Of Inflammatory Bowel Diseases
January 12th, 2010 Posted 1:00 am
GlaxoSmithKline (GSK) and ChemoCentryx, Inc. announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn’s disease…
Posted in Irritable Bowel Syndrome
Irritable Bowel Syndrome Does Not Respond To St. John’s Wort
January 6th, 2010 Posted 12:00 am
A Mayo Clinic research study published in the January issue of the American Journal of Gastroenterology finds that St. John’s wort is not an effective treatment for irritable bowel syndrome (IBS). While antidepressants are frequently used to treat IBS, to date, no study has examined the success of using the herbal supplement St. John’s wort in treating IBS…
Posted in Irritable Bowel Syndrome
Breakthrough On Causes Of Inflammatory Bowel Disease
January 1st, 2010 Posted 10:00 pm
New research by the University of Adelaide could help explain why some people are more prone to Crohn’s disease, ulcerative colitis and other autoimmune diseases. A critical imbalance of the regulatory cells required to control the immune system has been revealed among people suffering inflammatory bowel disease…
Posted in Irritable Bowel Syndrome